Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Status Epilepticus | 8 | 2020 | 18 | 0.540 |
Why?
|
| Epilepsy | 5 | 2005 | 82 | 0.500 |
Why?
|
| Anticonvulsants | 4 | 2005 | 65 | 0.450 |
Why?
|
| Electric Stimulation Therapy | 2 | 2020 | 14 | 0.330 |
Why?
|
| Drug Monitoring | 2 | 2005 | 27 | 0.300 |
Why?
|
| Valproic Acid | 1 | 2005 | 14 | 0.250 |
Why?
|
| Epilepsies, Partial | 2 | 2020 | 9 | 0.220 |
Why?
|
| Electroencephalography | 3 | 2017 | 72 | 0.210 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2022 | 1 | 0.200 |
Why?
|
| Frail Elderly | 1 | 2001 | 68 | 0.180 |
Why?
|
| Seizures | 4 | 2022 | 64 | 0.180 |
Why?
|
| Death | 1 | 1998 | 49 | 0.150 |
Why?
|
| Hemodynamics | 1 | 1998 | 155 | 0.150 |
Why?
|
| Neocortex | 1 | 2017 | 4 | 0.150 |
Why?
|
| Deep Brain Stimulation | 1 | 2017 | 49 | 0.140 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 124 | 0.130 |
Why?
|
| Adult | 11 | 2022 | 9375 | 0.130 |
Why?
|
| Urban Population | 1 | 1995 | 89 | 0.120 |
Why?
|
| Hippocampus | 1 | 2016 | 170 | 0.120 |
Why?
|
| Quality of Life | 1 | 2020 | 946 | 0.120 |
Why?
|
| Child, Preschool | 5 | 2005 | 1267 | 0.120 |
Why?
|
| Adolescent | 7 | 2020 | 3568 | 0.110 |
Why?
|
| Prospective Studies | 6 | 2020 | 2282 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2016 | 461 | 0.110 |
Why?
|
| Drug Therapy, Combination | 2 | 2005 | 288 | 0.100 |
Why?
|
| Child | 6 | 2005 | 2439 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 2263 | 0.100 |
Why?
|
| Aged | 7 | 2020 | 10308 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2022 | 3304 | 0.090 |
Why?
|
| Monitoring, Physiologic | 2 | 2003 | 73 | 0.090 |
Why?
|
| Humans | 14 | 2022 | 32082 | 0.090 |
Why?
|
| Fibrillar Collagens | 1 | 2008 | 1 | 0.080 |
Why?
|
| Procollagen | 1 | 2008 | 7 | 0.080 |
Why?
|
| Osteonectin | 1 | 2008 | 17 | 0.080 |
Why?
|
| Cardiomegaly | 1 | 2008 | 30 | 0.080 |
Why?
|
| Diseases in Twins | 2 | 1999 | 13 | 0.080 |
Why?
|
| Diastole | 1 | 2008 | 96 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 78 | 0.080 |
Why?
|
| Middle Aged | 7 | 2020 | 11834 | 0.080 |
Why?
|
| Myocardium | 1 | 2008 | 185 | 0.070 |
Why?
|
| Male | 9 | 2020 | 19202 | 0.070 |
Why?
|
| Female | 9 | 2020 | 19999 | 0.070 |
Why?
|
| Hospital Units | 1 | 2005 | 6 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2005 | 34 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2005 | 100 | 0.060 |
Why?
|
| Infant | 3 | 1998 | 1061 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2005 | 187 | 0.060 |
Why?
|
| Virginia | 4 | 1999 | 63 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2005 | 186 | 0.060 |
Why?
|
| Medication Therapy Management | 1 | 2022 | 12 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 261 | 0.050 |
Why?
|
| Young Adult | 2 | 2020 | 2665 | 0.050 |
Why?
|
| Metabolic Clearance Rate | 1 | 2001 | 17 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2001 | 77 | 0.050 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 22 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 33 | 0.040 |
Why?
|
| Suicide | 1 | 2020 | 20 | 0.040 |
Why?
|
| Coma | 1 | 2000 | 2 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 764 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2020 | 54 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2020 | 75 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2008 | 846 | 0.040 |
Why?
|
| Incidence | 3 | 2003 | 1199 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 629 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 510 | 0.040 |
Why?
|
| Epilepsy, Partial, Motor | 1 | 2017 | 1 | 0.040 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2017 | 2 | 0.040 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2017 | 8 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2017 | 41 | 0.040 |
Why?
|
| Mice | 2 | 2016 | 2474 | 0.030 |
Why?
|
| Time Factors | 2 | 1999 | 2145 | 0.030 |
Why?
|
| Heart Rate | 1 | 1998 | 335 | 0.030 |
Why?
|
| Thapsigargin | 1 | 2016 | 8 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 178 | 0.030 |
Why?
|
| Receptor, Insulin | 1 | 2016 | 10 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 294 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2016 | 46 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2016 | 33 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 95 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2016 | 65 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2016 | 84 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 164 | 0.030 |
Why?
|
| Cause of Death | 1 | 1995 | 236 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 632 | 0.030 |
Why?
|
| Survival Rate | 1 | 1995 | 876 | 0.030 |
Why?
|
| Neurons | 1 | 2016 | 407 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 680 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2000 | 3990 | 0.020 |
Why?
|
| Animals | 2 | 2016 | 7510 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 1995 | 1542 | 0.020 |
Why?
|
| Twins, Dizygotic | 2 | 1999 | 8 | 0.020 |
Why?
|
| Twins, Monozygotic | 2 | 1999 | 14 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2008 | 443 | 0.020 |
Why?
|
| Medical Records | 2 | 1998 | 76 | 0.020 |
Why?
|
| Prevalence | 2 | 2000 | 989 | 0.020 |
Why?
|
| Continental Population Groups | 2 | 1999 | 237 | 0.020 |
Why?
|
| Age Factors | 2 | 1999 | 1187 | 0.010 |
Why?
|
| Electrooculography | 1 | 2003 | 2 | 0.010 |
Why?
|
| Video Recording | 1 | 2003 | 59 | 0.010 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2003 | 59 | 0.010 |
Why?
|
| Inpatients | 1 | 2003 | 83 | 0.010 |
Why?
|
| Length of Stay | 1 | 2003 | 312 | 0.010 |
Why?
|
| Hypoxia, Brain | 1 | 2000 | 4 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2000 | 28 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1999 | 14 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2000 | 92 | 0.010 |
Why?
|
| Critical Care | 1 | 2000 | 105 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1999 | 65 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1999 | 191 | 0.010 |
Why?
|
| Age Distribution | 1 | 1999 | 206 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2003 | 1816 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2003 | 604 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1998 | 57 | 0.010 |
Why?
|
| African Continental Ancestry Group | 1 | 1999 | 363 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2000 | 673 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 516 | 0.010 |
Why?
|
| Sex Factors | 1 | 1999 | 667 | 0.010 |
Why?
|
| Registries | 1 | 1998 | 298 | 0.010 |
Why?
|
| Recurrence | 1 | 1996 | 263 | 0.010 |
Why?
|
| Mortality | 1 | 1996 | 125 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2003 | 3505 | 0.010 |
Why?
|
| European Continental Ancestry Group | 1 | 1999 | 1165 | 0.010 |
Why?
|
| Risk Factors | 1 | 1998 | 3880 | 0.010 |
Why?
|